Follow The Filings

CNXC Concentrix Corporation

Industrials, filed as CONCENTRIX CORP (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2

  • 1 Owner
  • Max 0.3%
  • $85M
  • 1 reduce

In 2026 Q3 Richard Pzena trimmed Concentrix.

Who owns this now

Largest portfolio weights among holders, up to 0.3% (Richard Pzena, Pzena Investment Management). Not free-float ownership.

  1. Richard Pzena Reduce 0.25%

Who owns CNXC

Sorted by value, long equity only, as of 2026 Q3.

History
Richard Pzena, Pzena Investment Management 0.25% Reduce −0.2% 3,408,338 $85M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CNXC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CNXC insider trades
  • $279K bought by 2 insiders
  • $134M sold by 1 insider outside a trading plan
  • $39K sold by 1 insider under 10b5-1 plans
  1. Christopher A Caldwell CEO
    Buy
    $21K 1,000 shares at $21.25 +0.3% to stake
    Traded Jul 8 Filed Jul 9
  2. Bruxelles Lambert Groupe 10% owner, +4 joint filers
    Sale
    $134M 6,000,000 shares at $22.25 68% of stake
    Traded Apr 29 Filed May 1
  3. Andre S Valentine CFO
    Buy
    $70K 2,500 shares at $27.95 +2.9% to stake
    Traded Apr 9 Filed Apr 9
  4. Christopher A Caldwell CEO
    Buy
    $27K 1,000 shares at $26.97 +0.3% to stake
    Traded Mar 26 Filed Mar 30
  5. Christopher A Caldwell CEO
    Buy
    $37K 1,000 shares at $37.07 +0.3% to stake
    Traded Jan 29 Filed Feb 2
  6. Cormac J Twomey EVP, Global Ops & Delivery
    Planned sale
    $18K 500 shares at $35.50 1.4% of stake
    Traded Nov 28, 2025 Filed Dec 2, 2025
  7. Christopher A Caldwell CEO
    Buy
    $40K 1,000 shares at $40.00 +0.3% to stake
    Traded Oct 31, 2025 Filed Nov 3, 2025
  8. Christopher A Caldwell CEO
    Buy
    $84K 2,000 shares at $42.03 +0.7% to stake
    Traded Oct 30, 2025 Filed Oct 31, 2025
  9. Cormac J Twomey EVP, Global Ops & Delivery
    Planned sale
    $21K 500 shares at $42.53 1.4% of stake
    Traded Oct 30, 2025 Filed Oct 31, 2025
  10. Christopher A Caldwell CEO
    Buy
    $45K 1,000 shares at $45.35 +0.3% to stake
    Traded Oct 10, 2025 Filed Oct 14, 2025

Also filed in the last 12 months, not counted as buying or selling: 24 share withholdings for taxes and 17 stock grants.

Congress

No member of Congress reported trading CNXC in the last three years. 1 member listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 5.02
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 5.02,9.01
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13D/A —
8-K 5.02
SCHEDULE 13G/A —
10-Q
8-K 5.02,5.07,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
8-K 1.01,2.03,9.01
DEFA14A
8-K 1.01,2.03,9.01

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $7.11B $9.62B $9.83B
Gross profit $2.58B $3.45B $3.44B
Gross margin * 36.2% 35.9% 35.0%
Net income $0.314B $0.251B -$1.28B
Net margin * 4.4% 2.6% -13.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $2.86B $2.84B $3.08B
Total non-current assets * $9.63B $9.15B $7.68B
Total assets $12.49B $11.99B $10.76B
Total current liabilities $2.07B $2B $2.2B
Total non-current liabilities * $6.27B $5.96B $5.82B
Total equity $4.14B $4.04B $2.74B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $678.01M $667.49M $806.97M
Cash from investing -$2.11B -$0.244B -$0.25B
Cash from financing $1.8B -$0.493B -$0.491B
Net change in cash $359.02M -$86.88M $91.52M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.